PGX® scores high in safety according to the FDA’s Adverse Events Reporting

Smaller Text Larger Text
The Nutriceutical Business & Technology magazine just released its September/October issue with the latest PGX case study findings

Correlating Pre-Clinical, Clinical and Post-Marketing Surveillance Data: A Case Study
 
The importance of dietary fibre to overall health and well-being represents an area that continues to evolve as traditional products are challenged by novel ones. PolyGlycopleX (PGX) is a unique functional fibre, a proprietary product with exceptional physiochemical properties. To ensure that consumers are able to access safe dietary supplements, manufacturers must address the difficult task of designing a set of metrics to assess any potential adverse events. How the assessment was accomplished in the case of PGX is the subject of this article.
 
Read pdf of article




Other News & Events